$786 Million is the total value of Iron Triangle Partners LP's 27 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 57.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EHC | Buy | ENCOMPASS HEALTH CORP | $63,473,000 | +53.5% | 775,000 | +55.0% | 8.07% | +50.6% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $59,531,000 | +28.2% | 160,000 | +20.8% | 7.57% | +25.7% |
| ZBH | ZIMMER BIOMET HOLDINGS INC | $59,230,000 | +3.9% | 370,000 | 0.0% | 7.53% | +1.9% | |
| MOH | Buy | MOLINA HEALTHCARE INC | $46,752,000 | +46.5% | 200,000 | +33.3% | 5.94% | +43.7% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $46,020,000 | -3.2% | 500,000 | -23.1% | 5.85% | -5.1% |
| LH | New | LABORATORY CORP AMER HLDGS | $43,355,000 | – | 170,000 | +100.0% | 5.51% | – |
| CRL | CHARLES RIV LABS INTL INC | $40,576,000 | +16.0% | 140,000 | 0.0% | 5.16% | +13.8% | |
| ALGN | New | ALIGN TECHNOLOGY INC | $37,907,000 | – | 70,000 | +100.0% | 4.82% | – |
| NVST | Buy | ENVISTA HOLDINGS CORPORATION | $37,128,000 | +22.2% | 910,000 | +1.0% | 4.72% | +19.9% |
| HAE | Buy | HAEMONETICS CORP MASS | $36,633,000 | +12.0% | 330,000 | +19.8% | 4.66% | +9.9% |
| ABBV | New | ABBVIE INC | $32,466,000 | – | 300,000 | +100.0% | 4.13% | – |
| SGRY | Sell | SURGERY PARTNERS INC | $32,089,000 | +20.3% | 725,000 | -21.1% | 4.08% | +18.0% |
| PACB | Buy | PACIFIC BIOSCIENCES CALIF IN | $31,172,000 | +50.2% | 935,805 | +17.0% | 3.96% | +47.3% |
| LUNG | New | PULMONX CORP | $27,444,000 | – | 600,000 | +100.0% | 3.49% | – |
| CNMD | Buy | CONMED CORP | $26,118,000 | +57.2% | 200,000 | +34.8% | 3.32% | +54.2% |
| NVRO | Buy | NEVRO CORP | $25,110,000 | -14.0% | 180,000 | +6.7% | 3.19% | -15.7% |
| IQV | Sell | IQVIA HLDGS INC | $19,314,000 | -24.6% | 100,000 | -30.1% | 2.46% | -26.1% |
| OSH | New | OAK STR HEALTH INC | $18,995,000 | – | 350,000 | +100.0% | 2.42% | – |
| IDXX | New | IDEXX LABS INC | $17,126,000 | – | 35,000 | +100.0% | 2.18% | – |
| GH | Sell | GUARDANT HEALTH INC | $15,265,000 | -28.6% | 100,000 | -39.8% | 1.94% | -30.0% |
| NTRA | NATERA INC | $15,231,000 | +2.0% | 150,000 | 0.0% | 1.94% | +0.1% | |
| EXAS | Sell | EXACT SCIENCES CORP | $13,178,000 | -80.1% | 100,000 | -80.0% | 1.68% | -80.5% |
| New | DERMTECH INC | $12,698,000 | – | 250,000 | +100.0% | 1.62% | – | |
| OHPAU | New | ORION ACQUISITION CORPunit 02/19/2026 | $10,989,000 | – | 1,100,000 | +100.0% | 1.40% | – |
| VCEL | Sell | VERICEL CORP | $8,888,000 | -50.4% | 160,000 | -72.4% | 1.13% | -51.3% |
| OM | Sell | OUTSET MED INC | $5,439,000 | -36.2% | 100,000 | -33.3% | 0.69% | -37.4% |
| RPRX | ROYALTY PHARMA PLC | $4,362,000 | -12.8% | 100,000 | 0.0% | 0.56% | -14.5% | |
| OMI | Exit | OWENS & MINOR INC NEW | $0 | – | -454,419 | -100.0% | -1.59% | – |
| DVA | Exit | DAVITA INC | $0 | – | -140,000 | -100.0% | -2.13% | – |
| CTLT | Exit | CATALENT INC | $0 | – | -160,000 | -100.0% | -2.16% | – |
| HRTX | Exit | HERON THERAPEUTICS INC | $0 | – | -865,072 | -100.0% | -2.37% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -75,000 | -100.0% | -3.59% | – |
| HCA | Exit | HCA HEALTHCARE INC | $0 | – | -280,000 | -100.0% | -5.97% | – |
| IWM | Exit | ISHARES TRput | $0 | – | -300,000 | -100.0% | -7.62% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 9.0% |
| GUARDANT HEALTH INC | 12 | Q3 2022 | 6.1% |
| CHARLES RIV LABS INTL INC | 11 | Q1 2023 | 7.8% |
| SURGERY PARTNERS INC | 11 | Q2 2023 | 6.4% |
| ICON PLC | 10 | Q3 2023 | 11.7% |
| BOSTON SCIENTIFIC CORP | 10 | Q3 2023 | 8.9% |
| NEVRO CORP | 10 | Q1 2022 | 6.7% |
| DEXCOM INC | 10 | Q3 2023 | 7.7% |
| ABBVIE INC | 9 | Q3 2023 | 8.1% |
| ACADIA HEALTHCARE COMPANY IN | 9 | Q3 2023 | 7.9% |
View Iron Triangle Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Iron Triangle Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.